Kangmei Pharma | 600518 - 销售和管理费用

金融业

CNY 1.34

CNY 13.07B

现金及等价物

CNY 1.23B

CNY 961.15M

CNY 6.66B

CNY 5.1B

CNY 173.71M

CNY -35.26M

CNY -12.72M

6.37K

EPS每股收益

CNY 0.01

股本和储备

CNY 7.83B

CNY 238.34M

债务利息支出

CNY 1.82M

CNY 2.44M

CNY 67.35M

CNY 18.99B

CNY 52.6M

CNY 1.22B

CNY -35.26M

普通股股本

CNY 13.83B

1.11K

CNY -14.01M

CNY 1.19B

销售和管理费用

CNY 253.72M

CNY 2.38B

贸易债权人

CNY 2.27B

应收帐款人

CNY 2.86B

	销售和管理费用	更改		日
Akebia Therapeutics	USD 23.53M		3.19M	2025-12
Alaunos Therapeutics	USD 424K		23K	2026-06
Avita Medical	AUD 19.54M		516K	2026-06
Cspc Pharmaceutical	CNY 1.87B		95.62M	2025-12
Dianthus Therapeutics	USD 13.56M		1.09M	2026-06
Genomma Lab Internacional	MXN 1.82B		140.89M	2026-09
Hypermarcas	BRL 403.62M		234.42M	2026-09
Ionis Pharmaceuticals	USD 130.07M		20.92M	2026-06
IQVIA Holdings	USD 569M		5M	2026-09
Jiangsu Hengrui	CNY 2.93B		143.13M	2026-09
Kangmei Pharma	CNY 253.72M		16.66M	2026-06
Moderna	USD 216M		43M	2026-06
Organon & Co	USD 407M		27M	2026-09
Revvity	USD 275.33M		3.25M	2026-09
Sh Fosun Pharma	CNY 3.07B		276.55M	2026-09
Tectonic Therapeutic	USD 6.17M		260K	2026-06
Viatris	USD 950.8M		183.7M	2026-09
Wuxi Apptec	CNY 1.25B		263.98M	2026-09
Xeris Pharmaceuticals	USD 61.04M		7.89M	2026-06
Zz Pientze Pharmaceu	CNY 267.85M		44.71M	2026-09